CSL Past Earnings Performance

Past criteria checks 5/6

CSL has been growing earnings at an average annual rate of 3.2%, while the Biotechs industry saw earnings growing at 7.7% annually. Revenues have been growing at an average rate of 11.2% per year. CSL's return on equity is 14%, and it has net margins of 17.9%.

Key information

3.2%

Earnings growth rate

1.6%

EPS growth rate

Biotechs Industry Growth-14.6%
Revenue growth rate11.2%
Return on equity14.0%
Net Margin17.9%
Next Earnings Update10 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How CSL makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:CSJA Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2414,8002,6422,3811,428
31 Mar 2414,4902,5572,3051,386
31 Dec 2314,1792,4722,2771,312
30 Sep 2313,7452,3332,3171,274
30 Jun 2313,3102,1942,3081,266
31 Mar 2312,5072,1562,1681,265
31 Dec 2211,7052,1182,0281,263
30 Sep 2211,1332,1861,8391,210
30 Jun 2210,5622,2551,6491,156
31 Mar 2210,5872,2901,7111,108
31 Dec 2110,6122,3251,7731,060
30 Sep 2110,4612,3501,7421,031
30 Jun 2110,3102,3751,7121,001
31 Mar 2110,1452,5201,612953
31 Dec 209,9802,6651,511904
30 Sep 209,5652,3841,550913
30 Jun 209,1512,1031,588922
31 Mar 209,0482,0541,557904
31 Dec 198,9442,0061,527886
30 Sep 198,7421,9621,484859
30 Jun 198,5391,9191,442832
31 Mar 198,4061,8611,441791
31 Dec 188,2741,8031,441751
30 Sep 188,0941,7661,371726
30 Jun 187,9151,7291,301702
31 Mar 187,6661,6741,251713
31 Dec 177,4171,6181,200723
30 Sep 177,1821,4781,191695
30 Jun 176,9471,3371,182667
31 Mar 176,8021,3331,118642
31 Dec 166,6561,3291,055617
30 Sep 166,3861,2861,033615
30 Jun 166,1151,2421,011614
31 Mar 165,9831,324954564
31 Dec 155,8501,406897513
30 Sep 155,6541,392841488
30 Jun 155,4591,379786463
31 Mar 155,4821,366768467
31 Dec 145,5051,354750471
30 Sep 145,4201,330773468
30 Jun 145,3351,307797466
31 Mar 145,1891,270803466
31 Dec 135,0421,233810466

Quality Earnings: CSJA has high quality earnings.

Growing Profit Margin: CSJA's current net profit margins (17.9%) are higher than last year (16.5%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CSJA's earnings have grown by 3.2% per year over the past 5 years.

Accelerating Growth: CSJA's earnings growth over the past year (20.4%) exceeds its 5-year average (3.2% per year).

Earnings vs Industry: CSJA earnings growth over the past year (20.4%) exceeded the Biotechs industry -18.2%.


Return on Equity

High ROE: CSJA's Return on Equity (14%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies